Needham Initiates Standard Nuclear at Buy With $18 Price Target

Seeking Alpha··US·Read original
3▲0 ▼0Impact / 5
Summary · why it matters

Needham initiated coverage of Standard Nuclear with a Buy rating and an $18 price target, sending shares up 10.8% in Tuesday's trading. Analyst Sean Milligan said the bullish thesis rests on the company's early operating and customer-acquisition advantage as the only merchant TRISO fuel fabricator currently making commercial shipments. He expects Standard Nuclear to replicate its modular production platform at SN-TN and SN-ID, converting a rapidly expanding commercial pipeline into funded backlog and scaling utilization as HALEU availability improves. Near-term proof points include U.S. Energy Department authorization, first qualified production from replicate facilities, and the Richland startup in 2027. Milligan noted that funded backlog rose from $8.2M to $119.3M in roughly five months, with total contract backlog of $576.9M and a qualified pipeline of $696M, adding that continued conversion should support utilization as new capacity comes online.

Impact on assets 1

Energy Transition & Power Demand▲

Theme Impact 3

Off-coverage companies 1

Standard Nucleari
Private± Mixedrelevance

Related news

CanadaUnited States
3

BWX Technologies' BANR Microreactor Chosen for Indigenous-Led Plant in Canada

Prodigy Clean Energy, together with Pabineau First Nation and Eel River Bar First Nation, selected BWX Technologies' BANR microreactor technology for an Indigenous-owned, transportable nuclear power plant in Belledune, New Brunswick, targeting in-service operation in the early 2030s with modular, factory-built units. The project is backed by a Government of New Brunswick power offtake letter and advances BWXT's push into transportable microreactors that could underpin future deployments across remote Canadian regions and export markets. The selection gives BWXT another reference project for its microreactor catalyst, though it does not materially reduce risks around contract concentration, commercial margin pressure, or execution on its expanding capital program. Among other recent announcements, BWXT received a US$4 million preliminary design award from the NNSA for a new Lithium Processing Facility at Y 12, which together with the Belledune project feeds the same nuclear-focused backlog story. The company's narrative projects $4.8 billion revenue and $539.9 million earnings by 2029, requiring 10.7% yearly revenue growth and a $184.7 million earnings increase from $355.2 million today, while the most pessimistic analysts model revenue of about US$4.5 billion and earnings of roughly US$519 million by 2029.
About megatrends
Energy Transition & Power Demand › Advanced Nuclear — SMR & Microreactor ▲Demand
Critical Materials & Supply Chain › Nuclear Fuel Fabrication & Fuel Technology Demand
BWXT · Demand · Positive BWXT's BANR microreactor was selected for an Indigenous-led transportable nuclear plant in New Brunswick, giving it a concrete reference project and backlog catalyst.
Prodigy Clean Energy · Demand · Positive Prodigy Clean Energy selected BWXT's BANR microreactor for its Indigenous-owned transportable nuclear plant project, advancing its deployment plans.
Read original ↗
Simply Wall St·20hRead more →
GlobalSwedenUnited StatesCanada
▼

Zacks Adds Volvo, Accendra Health and Cameco to Strong Sell List

Zacks Investment Research added three stocks to its Zacks Rank #5 Strong Sell List today. AB Volvo, which makes trucks, buses, construction equipment, and marine and industrial engines, saw its Zacks Consensus Estimate for current year earnings revised 2.3% downward over the last 60 days. Accendra Health, a healthcare solutions company, had its current year earnings estimate revised 109.4% downward over the same period. Cameco Corporation, which produces uranium fuel and provides nuclear energy solutions globally, saw its current year earnings estimate revised 12.2% downward over the last 60 days.
About megatrends
Critical Materials & Supply Chain › Uranium & Nuclear Fuel Cycle ▼Capital
Energy Transition & Power Demand › Uranium Mining & Development ▼Capital
Critical Materials & Supply Chain › Uranium Mining ▼Capital
Critical Materials & Supply Chain › Nuclear Fuel Fabrication & Fuel Technology ▼Capital
0HTP.LSE · Capital · Negative Zacks added AB Volvo to its Strong Sell list after a 2.3% downward revision to current-year earnings estimates.
ACH · Capital · Negative Zacks added Accendra Health to its Strong Sell list after a 109.4% downward revision to current-year earnings estimates.
CCJ · Capital · Negative Zacks added Cameco to its Strong Sell list after a 12.2% downward revision to current-year earnings estimates.
Read original ↗
Zacks Investment Research·5dRead more →
United States
▲

BWX Technologies Targets $5.5B-$6B 2030 Revenue After 27% Pullback

BWX Technologies held an investor day on September 29 where management laid out bullish long-term targets, after the stock fell 27% over the past three months. The company, which holds a virtual monopoly on naval nuclear reactors and fuel components for the U.S. Navy, said its total backlog has doubled to $8.4 billion, roughly nine quarters of contracted run rate, and projected 2026 revenue of $3.8 billion, about 98% of it from core nuclear activities. BWXT is selling a majority stake in its non-core medical isotope unit for up to $800 million while retaining a 20% interest, and is reallocating proceeds into nuclear manufacturing assets, including a 500,000-square-foot footprint expansion through the Precision Components Group acquisition. Its updated 2030 roadmap targets annual revenue of $5.5 billion to $6 billion on low double-digit compound organic growth, with adjusted EBITDA margins expanding from 17.5% to approximately 20% and cumulative free cash flow exceeding $2 billion through the end of the decade. The stock, which peaked above $241 and has traded down into the $130-$140 range, still carries a roughly 36x trailing and 27x forward price-to-earnings multiple, while hedge fund holders rose to 65 in the second quarter from 61 in the prior quarter and short interest sits at 4.42% of the public float.
About megatrends
Defense & Geopolitical Fragmentation › Naval Systems & Shipbuilding ▲Supply
Critical Materials & Supply Chain › Nuclear Fuel Fabrication & Fuel Technology ▲Supply
Energy Transition & Power Demand › Advanced Nuclear — SMR & Microreactor Supply
BWXT · Capital · Positive Investor day lays out bullish 2030 revenue/EBITDA/FCF targets, doubled $8.4B backlog, and a $800M medical-isotope divestiture reallocating proceeds into nuclear manufacturing.
Read original ↗
Insider Monkey·6dRead more →
United States

NANO Nuclear Signs Definitive Agreement to Acquire NRC-Licensed U.S. Nuclear Fuel Processing Assets

NANO Nuclear Energy Inc. and its wholly owned subsidiary HALEU Energy Fuel Inc. have entered into a definitive asset purchase agreement with Radnostix, Inc., formerly International Isotopes Inc., and its subsidiary International Isotopes Fluorine Products, Inc. to acquire strategic U.S. nuclear fuel processing assets, including a U.S. Nuclear Regulatory Commission license and related intellectual property and technical materials tied to a previously planned depleted uranium hexafluoride deconversion and fluorine extraction facility in Lea County, New Mexico. Upon completion of the transaction and transfer of the NRC license, NANO Nuclear would own one of ten NRC-licensed fuel cycle facilities in the United States. Under the agreement, consideration at closing is $9.5 million in cash and $4.0 million in NANO common stock, with closing subject to NRC consent to the license transfer, other required approvals and consents including from New Mexico officials, satisfactory site arrangements and other closing conditions, and the parties currently expect closing in approximately 90 to 120 days. The NRC license was originally issued to construct and operate the DUF6 deconversion and fluorine extraction facility, which was never built, and the acquisition also includes related patented technology, engineering and safety analyses, regulatory and permitting materials, equipment and historical project development records. NANO Nuclear said the existing licensed asset could offer a significantly more efficient regulatory pathway than developing and licensing a comparable facility on a new site, and that no final investment decision has been made on the optimal commercial and development pathway for the acquired assets.
About megatrends
Critical Materials & Supply Chain › Conversion, Enrichment & Fuel ▲Supply
Critical Materials & Supply Chain › Uranium & Nuclear Fuel Cycle ▲Supply
Energy Transition & Power Demand › Nuclear Fuel Cycle (Uranium & Enrichment) ▲Supply
Energy Transition & Power Demand › Conversion & Enrichment (HALEU) Supply
Critical Materials & Supply Chain › Nuclear Fuel Fabrication & Fuel Technology Supply
Energy Transition & Power Demand › Advanced Nuclear — SMR & Microreactor ▲Supply
NNE · Capital · Positive NANO Nuclear signed a definitive agreement to acquire NRC-licensed nuclear fuel processing assets for $9.5M cash plus $4.0M in stock, expanding its licensed fuel cycle footprint.
Radnostix, Inc. · Capital · Positive Radnostix (formerly International Isotopes) is the seller divesting its NRC-licensed DUF6 deconversion and fluorine extraction assets for $9.5M cash and $4.0M in NANO stock.
HALEU Energy Fuel Inc. · Capital · Positive HALEU Energy Fuel Inc., NANO's subsidiary, is the acquirer of the NRC license and related fuel processing assets, advancing its HALEU fuel capabilities.
International Isotopes Fluorine Products, Inc. · Capital · Positive International Isotopes Fluorine Products is the subsidiary selling the NRC-licensed deconversion facility assets and related IP to NANO Nuclear.
Read original ↗
GlobeNewswire·9dRead more →